Concepedia

Treatment of refractory giant cell arteritis with cyclophosphamide:a retrospective analysis of 35 patients from three centres.

J. Loock, Jörg Henes, Ina Kötter, Torsten Witte, Peter Lamprecht, Michael Schirmer, Wolfgang L. Gross

PubMed · 2012 · 48 citations · 13 references

Abstract

Cyclophosphamide can be considered a therapeutic option with an acceptable safety profile for remission induction in GCA refractory to standard immunosuppressive treatment.

References

13

The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis

Gene G. Hunder, D. Blöch, Beat A. Michel et al. · Arthritis & Rheumatism · 1990 · 2.5K citations

EULAR recommendations for the management of primary small and medium vessel vasculitis

Chetan Mukhtyar, Loı̈c Guillevin, María C. Cid et al. · Annals of the Rheumatic Diseases · 2008 · 984 citations · Full text

EULAR recommendations for the management of large vessel vasculitis

Chetan Mukhtyar, Loı̈c Guillevin, María C. Cid et al. · Annals of the Rheumatic Diseases · 2008 · 665 citations · Full text

Glucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes

Anne Prøven, Sherine E. Gabriel, Carlos H. Orces et al. · Arthritis Care & Research · 2003 · 596 citations

Increased Incidence of Aortic Aneurysm and Dissection in Giant Cell (Temporal) Arteritis: A Population-Based Study

Jonathan M. Evans · Annals of Internal Medicine · 1995 · 585 citations